Paclitaxel oral solution versus paclitaxel injection as second-line therapy for advanced gastric cancer: a multicenter, open-label, randomized phase III trial.

Li J, Huang M, Deng T, Bai Y, Liu T, Pan Y, Yu J, Pan H, Xu H, Wang J, Ye F, Wang J, Wu J, Cang S, Chen K, Zhang J, Zhang J, Ling Y, Zhong H, Fu G, Liu H, Huang L, Pan Y, Zhang L, Liu L, Ye X, Wu M, Zheng Z, Huang J, Liang X, Liu Y, Ding Y, Bai C, Yang L, Yan P, Miao J, Lu H, Bi Q, Zhou Y, Peng Y, Lin H, Deng Y, Zhong D, Gao C, Liu H, Tan S, Yi T, Liu Y, Song L, Chen Y, Qin S

Open source

DOI: 10.1016/j.esmoop.2026.108312
Published: 2026 Sep
Container: ESMO open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.esmoop.2026.108312,
  title = {Paclitaxel oral solution versus paclitaxel injection as second-line therapy for advanced gastric cancer: a multicenter, open-label, randomized phase III trial.},
  author = {Li J and Huang M and Deng T and Bai Y and Liu T and Pan Y and Yu J and Pan H and Xu H and Wang J and Ye F and Wang J and Wu J and Cang S and Chen K and Zhang J and Zhang J and Ling Y and Zhong H and Fu G and Liu H and Huang L and Pan Y and Zhang L and Liu L and Ye X and Wu M and Zheng Z and Huang J and Liang X and Liu Y and Ding Y and Bai C and Yang L and Yan P and Miao J and Lu H and Bi Q and Zhou Y and Peng Y and Lin H and Deng Y and Zhong D and Gao C and Liu H and Tan S and Yi T and Liu Y and Song L and Chen Y and Qin S},
  year = {2026},
  journal = {ESMO open},
  doi = {10.1016/j.esmoop.2026.108312},
  url = {https://doi.org/10.1016/j.esmoop.2026.108312}
}

RIS

TY  - JOUR
TI  - Paclitaxel oral solution versus paclitaxel injection as second-line therapy for advanced gastric cancer: a multicenter, open-label, randomized phase III trial.
AU  - Li J
AU  - Huang M
AU  - Deng T
AU  - Bai Y
AU  - Liu T
AU  - Pan Y
AU  - Yu J
AU  - Pan H
AU  - Xu H
AU  - Wang J
AU  - Ye F
AU  - Wang J
AU  - Wu J
AU  - Cang S
AU  - Chen K
AU  - Zhang J
AU  - Zhang J
AU  - Ling Y
AU  - Zhong H
AU  - Fu G
AU  - Liu H
AU  - Huang L
AU  - Pan Y
AU  - Zhang L
AU  - Liu L
AU  - Ye X
AU  - Wu M
AU  - Zheng Z
AU  - Huang J
AU  - Liang X
AU  - Liu Y
AU  - Ding Y
AU  - Bai C
AU  - Yang L
AU  - Yan P
AU  - Miao J
AU  - Lu H
AU  - Bi Q
AU  - Zhou Y
AU  - Peng Y
AU  - Lin H
AU  - Deng Y
AU  - Zhong D
AU  - Gao C
AU  - Liu H
AU  - Tan S
AU  - Yi T
AU  - Liu Y
AU  - Song L
AU  - Chen Y
AU  - Qin S
PY  - 2026
JO  - ESMO open
DO  - 10.1016/j.esmoop.2026.108312
UR  - https://doi.org/10.1016/j.esmoop.2026.108312
ER  -

APA

J, L., M, H., T, D., Y, B., T, L., Y, P., J, Y., H, P., H, X., J, W., F, Y., J, W., J, W., S, C., K, C., J, Z., J, Z., Y, L., H, Z., G, F., H, L., L, H., Y, P., L, Z., L, L., X, Y., M, W., Z, Z., J, H., X, L., Y, L., Y, D., C, B., L, Y., P, Y., J, M., H, L., Q, B., Y, Z., Y, P., H, L., Y, D., D, Z., C, G., H, L., S, T., T, Y., Y, L., L, S., Y, C., & S, Q. (2026). Paclitaxel oral solution versus paclitaxel injection as second-line therapy for advanced gastric cancer: a multicenter, open-label, randomized phase III trial.. ESMO open. https://doi.org/10.1016/j.esmoop.2026.108312

Source records

pubmed · retrieved 2026-09-26T06:05:55.467Z